Jump to content

Svitlana Zbrozgek: Difference between revisions

From Medico-Pharmaceutical Law Universe (by Lumen SI)
Expand source-linked author records; preserve work-specific attribution
 
Add complete multilingual reference and language navigation
 
Line 1: Line 1:
<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Svitlana Zbrozgek|English]] · [[Svitlana Zbrozgek/uk|Українська]] · [[Svitlana Zbrozgek/es|Español]] · [[Svitlana Zbrozgek/fr|Français]] · [[Svitlana Zbrozgek/de|Deutsch]] · [[Svitlana Zbrozgek/pt|Português]]</div>
'''Svitlana Zbrozgek''' is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography.
'''Svitlana Zbrozgek''' is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography.



Latest revision as of 00:52, 12 November 2026

Svitlana Zbrozgek is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography.

Documented work

Sole author of a 2021 paper on healthcare reform and medicine availability during the COVID-19 pandemic.

Research context: Documentary and legal analysis with proposed regulatory changes. These are historical proposals, not a statement of current law.

Identity and evidence notes

The source byline uses Zbrozgek; cited publications also use Zbrozhek. This particular paper is sole-authored and must not be converted into a coauthor edge.

Inclusion records authorship of the cited work, not endorsement of every later Vision 2035 proposal. Publication affiliations are historical unless separately updated.

See People and attribution and Research network.